- Home
- RNG vs AAPG Comparison
RNG vs AAPG Comparison
Compare RNG & AAPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNG
- AAPG
- Stock Information
- Founded
- RNG 1999
- AAPG 2009
- Country
- RNG United States
- AAPG China
- Employees
- RNG 4260
- AAPG N/A
- Industry
- RNG EDP Services
- AAPG Biotechnology: Pharmaceutical Preparations
- Sector
- RNG Technology
- AAPG Health Care
- Exchange
- RNG Nasdaq
- AAPG Nasdaq
- Market Cap
- RNG 2.3B
- AAPG 2.2B
- IPO Year
- RNG 2013
- AAPG 2025
- Fundamental
- Price
- RNG $26.71
- AAPG $37.38
- Analyst Decision
- RNG Buy
- AAPG Buy
- Analyst Count
- RNG 15
- AAPG 1
- Target Price
- RNG $34.00
- AAPG N/A
- AVG Volume (30 Days)
- RNG 974.2K
- AAPG 14.3K
- Earning Date
- RNG 07-31-2025
- AAPG 08-06-2025
- Dividend Yield
- RNG N/A
- AAPG N/A
- EPS Growth
- RNG N/A
- AAPG N/A
- EPS
- RNG N/A
- AAPG N/A
- Revenue
- RNG $2,428,240,000.00
- AAPG $134,352,180.00
- Revenue This Year
- RNG $5.82
- AAPG N/A
- Revenue Next Year
- RNG $5.51
- AAPG $389.09
- P/E Ratio
- RNG N/A
- AAPG N/A
- Revenue Growth
- RNG 7.78
- AAPG 341.77
- 52 Week Low
- RNG $20.59
- AAPG $16.50
- 52 Week High
- RNG $42.19
- AAPG $37.95
- Technical
- Relative Strength Index (RSI)
- RNG 50.54
- AAPG N/A
- Support Level
- RNG $25.51
- AAPG N/A
- Resistance Level
- RNG $28.23
- AAPG N/A
- Average True Range (ATR)
- RNG 0.71
- AAPG 0.00
- MACD
- RNG -0.03
- AAPG 0.00
- Stochastic Oscillator
- RNG 48.12
- AAPG 0.00
About RNG RingCentral Inc.
RingCentral is a unified communications as a service, or UCaaS, provider. Its software helps users communicate and collaborate via voice, video, and messaging across all device types and all from one platform. RingCentral helps customers modernize and move from legacy on-premises systems to modern, cloud-based systems. Beyond its core RingCentral MVP solution, RingCentral also offers a cloud-based contact center solution, a stand-alone video meetings solution, and webinars.
About AAPG Ascentage Pharma Group International American Depository Shares
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.